![]()
![]()
![]()
Fig. 1. Representative characterizations and in vitro delivery of WNP and other delivery systems.
![]()
Fig. 2.
In vivodelivery of WNP and other delivery systems.
![]()
Fig. 3. Design of SARS-CoV-2 RBD(M5)-hFc mRNA and safety evaluation of WNP .
![]()
Fig. 4. Comparation of humoral immune responses and cellular immune responses triggered by different mRNA vaccines in mice.
![]()
Fig. 5. Comparation of protective efficacy against Omicron BA.1 triggered by different mRNA vaccines.
![]()
Fig. 6. Comparation of protective efficacy against XBB.1.5-ΔN-GFP replicon delivery particles triggered by different mRNA vaccines.
![]()
Supplementary Figure S1. Full dilution-inhibition profiles and curve fitting parameters.
![]()
Supplementary Figure S2. Gating strategy for flow cytometry analysis.
欢迎来到医食参考新媒体矩阵
2023年疫苗接种攻略
阳过了,该怎么打疫苗?最全接种指导手册来了
撰写| 中国病毒学英文版
校稿| Gddra编审| Hide / Blue sea
编辑 设计| Alice
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.